| Product Code: ETC9280723 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Parkinsons Disease Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Singapore Parkinsons Disease Market - Industry Life Cycle |
3.4 Singapore Parkinsons Disease Market - Porter's Five Forces |
3.5 Singapore Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Singapore Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Singapore Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Singapore Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Singapore Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Singapore Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in Singapore due to an aging population. |
4.2.2 Advancements in research and development leading to improved diagnosis and treatment options. |
4.2.3 Growing awareness and initiatives for early detection and management of Parkinson's disease. |
4.3 Market Restraints |
4.3.1 High treatment costs associated with Parkinson's disease medications and therapies. |
4.3.2 Limited access to specialized healthcare services and facilities for Parkinson's patients in Singapore. |
5 Singapore Parkinsons Disease Market Trends |
6 Singapore Parkinsons Disease Market, By Types |
6.1 Singapore Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Singapore Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Singapore Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Singapore Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Singapore Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Singapore Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Singapore Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Singapore Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Singapore Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Singapore Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Singapore Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Singapore Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Singapore Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Singapore Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Singapore Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Singapore Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Singapore Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Singapore Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Singapore Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Singapore Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Singapore Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Singapore Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Singapore Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Singapore Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Singapore Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Singapore Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Singapore Parkinsons Disease Market Export to Major Countries |
7.2 Singapore Parkinsons Disease Market Imports from Major Countries |
8 Singapore Parkinsons Disease Market Key Performance Indicators |
8.1 Number of new clinical trials and research studies conducted in Singapore related to Parkinson's disease. |
8.2 Percentage increase in early diagnosis rates of Parkinson's disease in Singapore. |
8.3 Adoption rate of innovative treatment options and therapies for Parkinson's disease in the healthcare system in Singapore. |
9 Singapore Parkinsons Disease Market - Opportunity Assessment |
9.1 Singapore Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Singapore Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Singapore Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Singapore Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Singapore Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Singapore Parkinsons Disease Market - Competitive Landscape |
10.1 Singapore Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Singapore Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here